Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revitaprocedure maintained weight loss after GLP-1 ...

Learn how new agreements aim to lower the cost of weight loss drugs like Wegovy and Zepbound for both insured and uninsured ...

New research suggests drugs like Wegovy and Ozempic may also lower the risk of early death in colon cancer patients.

WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched ...

Amy Schumer is starting fresh on social media. On Tuesday night, Schumer revealed that she had deleted all her ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the rise in chronic kidney disease ...

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

When Novo Nordisk CEO Mike Doustdar learned in late September that Metsera had accepted a $7.3 billion rival bid from Pfizer ...

Amy Schumer deleted every Instagram photo and debuted her slimmer figure in a red mini dress, telling fans she feels “good ...

PlushCare offers telemedicine services for non-emergency medical concerns, including weight management. As part of its weight ...

An ultra-long-acting GLP-1 was tied to weight loss of up to 12.5% at 28 weeks among adults with overweight or obesity with no ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...